Is denosumab associated with an increased risk for infection in patients with low bone mineral density? A systematic review and meta ‐analysis of randomized controlled trials

ConclusionDenosumab ‐treated patients with low bone mineral density have slightly increased incidence of SAEI compared with placebo, but not when compared with bisphosphonates. Application of these results requires consideration of the entire body of data available regarding denosumab safety.
Source: International Journal of Rheumatic Diseases - Category: Rheumatology Authors: Tags: ORIGINAL ARTICLE Source Type: research